Production (Stage)
Chemed Corporation
CHE
$569.57
$8.131.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.49B | 2.43B | 2.38B | 2.34B | 2.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.49B | 2.43B | 2.38B | 2.34B | 2.29B |
| Cost of Revenue | 1.62B | 1.58B | 1.53B | 1.50B | 1.48B |
| Gross Profit | 866.66M | 854.35M | 847.80M | 839.98M | 813.47M |
| SG&A Expenses | 414.07M | 419.02M | 415.21M | 412.83M | 405.56M |
| Depreciation & Amortization | 63.26M | 63.05M | 62.76M | 62.44M | 61.87M |
| Other Operating Expenses | -41.00K | 0.00 | -1.78M | -1.59M | -1.65M |
| Total Operating Expenses | 2.10B | 2.06B | 2.01B | 1.97B | 1.95B |
| Operating Income | 389.36M | 372.28M | 371.61M | 366.30M | 347.68M |
| Income Before Tax | 410.65M | 399.47M | 394.94M | 387.17M | 363.69M |
| Income Tax Expenses | 101.92M | 97.47M | 93.20M | 86.26M | 80.28M |
| Earnings from Continuing Operations | 308.74 | 302.00 | 301.73 | 300.92 | 283.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 308.74M | 302.00M | 301.73M | 300.92M | 283.41M |
| EBIT | 389.36M | 372.28M | 371.61M | 366.30M | 347.68M |
| EBITDA | 448.32M | 431.03M | 429.86M | 424.24M | 405.06M |
| EPS Basic | 20.73 | 20.12 | 20.00 | 19.93 | 18.78 |
| Normalized Basic EPS | 17.25 | 16.87 | 16.68 | 16.34 | 15.38 |
| EPS Diluted | 20.54 | 19.92 | 19.79 | 19.72 | 18.58 |
| Normalized Diluted EPS | 17.08 | 16.69 | 16.49 | 16.16 | 15.21 |
| Average Basic Shares Outstanding | 59.60M | 60.10M | 60.34M | 60.39M | 60.35M |
| Average Diluted Shares Outstanding | 60.18M | 60.75M | 61.03M | 61.06M | 61.03M |
| Dividend Per Share | 1.90 | 1.80 | 1.70 | 1.60 | 1.58 |
| Payout Ratio | 9.19% | 8.97% | 8.50% | 8.04% | 8.42% |